Jeffrey S Hyams
14PUBLICATIONS
27CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (14)
Sort by Publication Date:
|Jan 08, 2026
Efficacy, Safety, and Pharmacokinetics of Golimumab in Children with Moderately-To-Severely Active Ulcerative Colitis: Results from the PURSUIT 2 Study.Dan Turner, Kathleen G Lomax, Gigi Veereman
|Nov 05, 2025
Model-Informed Deep Q-Networks to Guide Infliximab Dosing in Pediatric Crohn's Disease.Kei Irie, Phillip Minar, Jack Reifenberg
|Nov 29, 2024
Change from originator infliximab to biosimilar does not affect 1-year outcome in children with inflammatory bowel disease.Viven Solomon, Sydney Kuzoian, Genesis Michel
|Jul 31, 2023
Recommendations for Standardizing MRI-based Evaluation of Perianal Fistulizing Disease Activity in Pediatric Crohn's Disease Clinical Trials.Eileen Crowley, Christopher Ma, Leonard Guizzetti
|Oct 31, 2022
Real world population pharmacokinetic study in children and young adults with inflammatory bowel disease discovers novel blood and stool microbial predictors of vedolizumab clearance.Ruben J Colman, Tomoyuki Mizuno, Keizo Fukushima
|Dec 22, 2021
Antibodies-to-infliximab accelerate clearance while dose intensification reverses immunogenicity and recaptures clinical response in paediatric Crohn's disease.Ruben J Colman, Ye Xiong, Tomoyuki Mizuno
Pageof 3
Frequent Collaborators
3 joint publications
Tomoyuki Mizuno
3 joint publications
Phillip Minar
2 joint publications
Ruben J Colman
2 joint publications
Johan van Limbergen
2 joint publications
Lee A Denson
2 joint publications
Alexander A Vinks
1 joint publications
Ryan C Ungaro
1 joint publications
Julia K Carmody
1 joint publications
Thomas Walters
1 joint publications
Derya Unutmaz
